Podme logo
KotiLöydäKategoriatEtsiOpiskelijoille
The new drug plaguing US cities

The new drug plaguing US cities

21:412023-02-17

Jaksokuvaus

A tranquiliser used by vets is infiltrating street drugs and deepening addiction across cities in the US. The drug called xylazine is causing wounds so severe that without treatment results in amputation. The problem is particularly bad in Philadelphia – which has long been ground zero for the opioid crisis. On this edition of the Sky News Daily Niall Paterson talks to US Correspondent, Mark Stone who has been to the city and to Professor Paul Cristo from John Hopkins University about the on going opioid crisis in the US. Podcast producers: Rosie Gillott and Emma-Rae Woodhouse Interviews Producer: Alex Edden Junior podcast producer: Charlie Bell Editor Philly Beaumont

Uusimmat jaksot

Sky News Daily
Sky News Daily

Will Biden fight on?

2024-07-0417min
Sky News Daily
Sky News Daily

The stories from the election battle buses

2024-07-0327min
Sky News Daily
Sky News Daily

The British companies keeping Russian gas flowing into Europe

2024-07-0221min
Sky News Daily
Sky News Daily

Five things the main parties aren't mentioning this election... and how exit polls are done

2024-07-0118min
Sky News Daily
Sky News Daily

Can Joe Biden carry on?

2024-06-2823min
Sky News Daily
Sky News Daily

Gareth Southgate: How do you lead a team that’s not performing?

2024-06-2722min
Sky News Daily
Sky News Daily

Does 'gamblegate' mean the Conservatives are a busted flush for voters?

2024-06-2619min
Sky News Daily
Sky News Daily

Is this the end of the Assange story?

2024-06-2522min
Sky News Daily
Sky News Daily

What could have happened to Jay Slater?

2024-06-2419min
Sky News Daily
Sky News Daily

Why won't politicians really talk about social care?

2024-06-2121min
logo

PODME

TIEDOT

  • Evästekäytäntö
  • Käyttöehdot
  • Tietosuojakäytäntö
  • Medialle

LATAA SOVELLUKSEMME!

app storegoogle play store

ALUEELLA

flag
  • sweden_flag
  • norway_flag
  • finland_flag

© Podme AB 2024